, Volume 192, Issue 2, pp 259–265 | Cite as

Factors Associated with a Low Level of Physical Activity in Patients with Chronic Obstructive Pulmonary Disease

  • Marc MiravitllesEmail author
  • Jordi Cantoni
  • Karlos Naberan



Physical activity such as walking is strongly recommended for patients with chronic obstructive pulmonary disease (COPD).


We undertook a multicenter observational study on COPD patients, collecting the daily walking time, COPD severity score (COPDSS), functional status [London Chest Activity of Daily Living (LCADL) questionnaire], health-related quality of life (QoL) rating [five-item EuroQL (EQ-5D) and Airways Questionnaire 20 (AQ20)], and anxiety and depression rating (Hospital Anxiety and Depression Scale). Multivariate logistic regression modeling was performed to identify the independent predictors of a low walking time (<30 min/day).


We included 4,574 patients with a mean (±standard deviation) age of 67.1 ± 10.0 years, with a mean FEV1 (%) of 54.0 ± 23.7. The mean daily walking time was 73.6 ± 67.1 min (58.9 % at ≥60 min and 13.7 % at <30 min). A strong direct relationship was observed between daily walking time and better QoL (EQ-5D and AQ20) and functional status (LCADL; p < 0.001 in all cases). The independent predictors of a low walking time were a worse score in EQ-5D [odds ratio (OR) (95 % confidence interval per one-point increase of 0.23 (0.15–0.35)], a higher COPDSS [OR per one-point increase of 1.04 (1.02–1.07)], and the presence of depression [OR 1.58 (1.25–2.01)].


After adjustment for age and severity of symptoms, poor health status, severity of COPD, and depression are the main factors associated with a low walking time in COPD patients.


Physical activity COPD Quality of life Anxiety Depression 



Funding was provided by Laboratorios Esteve S.A. (Barcelona, Spain). We thank Angel Azpeitia (Laboratorios Esteve S.A., Barcelona Spain) for his support in the design of the study.

Conflict of interest

Marc Miravitlles has received speaker fees from Boehringer Ingelheim, Pfizer, AstraZeneca, Bayer Schering, Novartis, Talecris, Takeda-Nycomed, Merck, and Sharp and Dohme; honoraria for the design and development of the current study from Laboratorios Esteve S.A. (Barcelona, Spain); and consulting fees from Boehringer Ingelheim, Pfizer, GlaxoSmithKline, AstraZeneca, Bayer Schering, Novartis, Almirall, Merck, Sharp and Dohme, and Takeda-Nycomed. The rest of the authors have no conflicts of interest related to this article.


  1. 1.
    Decramer M, Janssens W, Miravitlles M (2012) Chronic obstructive pulmonary disease. Lancet 379(9823):1341–1351CrossRefPubMedGoogle Scholar
  2. 2.
    Miravitlles M, Soriano JB, Garcia-Rio F, Muñoz L, Duran-Tauleria E, Sanchez G et al (2009) Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily life activities. Thorax 64(10):863–868CrossRefPubMedGoogle Scholar
  3. 3.
    Donaire-Gonzalez D, Gimeno-Santos E, Balcells E, Rodriguez DA, Farrero E, Batlle JD et al (2013) Physical activity in COPD patients: patterns and bouts. Eur Respir J 42(4):993–1002CrossRefPubMedGoogle Scholar
  4. 4.
    Nelson ME, Rejeski WJ, Blair SN, Duncan PW, Judge JO, King AC et al (2007) Physical activity and public health in older adults: recommendation from the American College of Sports Medicine and the American Heart Association. Med Sci Sports Exerc 39(8):1435–1445CrossRefPubMedGoogle Scholar
  5. 5.
    Pitta F, Troosters T, Spruit MA, Probst VS, Decramer M, Gosselink R (2005) Characteristics of physical activities in daily life in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 171(9):972–977CrossRefPubMedGoogle Scholar
  6. 6.
    van Gestel AJ, Clarenbach CF, Stowhas AC, Rossi VA, Sievi NA, Camen G et al (2012) Predicting daily physical activity in patients with chronic obstructive pulmonary disease. PLoS ONE 7(11):e48081PubMedCentralCrossRefPubMedGoogle Scholar
  7. 7.
    Bourbeau J (2009) Activities of life: the COPD patient. COPD 6(3):192–200CrossRefPubMedGoogle Scholar
  8. 8.
    Waschki B, Kirsten A, Holz O, Muller KC, Meyer T, Watz H et al (2011) Physical activity is the strongest predictor of all-cause mortality in patients with COPD: a prospective cohort study. Chest 140(2):331–342CrossRefPubMedGoogle Scholar
  9. 9.
    Miravitlles M, Naberan K, Cantoni J, Azpeitia A (2011) Socioeconomic status and health-related quality of life of patients with chronic obstructive pulmonary disease. Respiration 82(5):402–408CrossRefPubMedGoogle Scholar
  10. 10.
    Naberan K, Azpeitia A, Cantoni J, Miravitlles M (2012) Impairment of quality of life in women with chronic obstructive pulmonary disease. Respir Med 106(3):367–373CrossRefPubMedGoogle Scholar
  11. 11.
    Esteban C, Quintana JM, Aburto M, Moraza J, Egurrola M, Perez-Izquierdo J et al (2010) Impact of changes in physical activity on health-related quality of life among patients with COPD. Eur Respir J 36(2):292–300CrossRefPubMedGoogle Scholar
  12. 12.
    Charlson M, Szatrowski TP, Peterson J, Gold J (1994) Validation of a combined comorbidity index. J Clin Epidemiol 47(11):1245–1251CrossRefPubMedGoogle Scholar
  13. 13.
    Eisner MD, Trupin L, Katz PP, Yelin EH, Earnest G, Balmes J et al (2005) Development and validation of a survey-based COPD severity score. Chest 127(6):1890–1897CrossRefPubMedGoogle Scholar
  14. 14.
    Miravitlles M, Llor C, de Castellar R, Izquierdo I, Baro E, Donado E (2009) Validation of the COPD severity score for use in primary care: the NEREA study. Eur Respir J 33(3):519–527CrossRefPubMedGoogle Scholar
  15. 15.
    Vilaró J, Gimeno E, Sánchez-Férez N, Hernando C, Diaz I, Ferrerc M et al (2007) Daily living activity in chronic obstructive pulmonary disease: validation of the Spanish version and comparative analysis of 2 questionnaires. Med Clin (Barc) 129(9):326–332CrossRefGoogle Scholar
  16. 16.
    Garrod R, Bestall JC, Paul EA, Wedzicha JA, Jones PW (2000) Development and validation of a standardized measure of activity of daily living in patients with severe COPD: the London Chest Activity of Daily Living scale (LCADL). Respir Med 94(6):589–596CrossRefPubMedGoogle Scholar
  17. 17.
    EuroQol Group (1990) EuroQol—a new facility for the measurement of health-related quality of life. The EuroQol Group. Health Policy 16(3):199–208CrossRefGoogle Scholar
  18. 18.
    Badia X, Roset M, Montserrat S, Herdman M, Segura A (1999) The Spanish version of EuroQol: a description and its applications. European Quality of Life scale. Med Clin (Barc) 112(Suppl 1):79–85Google Scholar
  19. 19.
    Blanco-Aparicio M, Vazquez-Rodriguez I, Verea-Hernando H (2009) Cultural adaptation into Spanish of the Airways Questionnaire 20, a short health-related quality-of-life questionnaire for the clinical evaluation of asthma and chronic obstructive pulmonary disease. Arch Bronconeumol 45(1):24–29CrossRefPubMedGoogle Scholar
  20. 20.
    Hajiro T, Nishimura K, Jones PW, Tsukino M, Ikeda A, Koyama H et al (1999) A novel, short, and simple questionnaire to measure health-related quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 159(6):1874–1878CrossRefPubMedGoogle Scholar
  21. 21.
    Herrero MJ, Blanch J, Peri JM, De Pablo J, Pintor L, Bulbena A (2003) A validation study of the hospital anxiety and depression scale (HADS) in a Spanish population. Gen Hosp Psychiatry 25(4):277–283CrossRefPubMedGoogle Scholar
  22. 22.
    Bossenbroek L, de Greef MH, Wempe JB, Krijnen WP, Ten Hacken NH (2011) Daily physical activity in patients with chronic obstructive pulmonary disease: a systematic review. COPD 8(4):306–319CrossRefPubMedGoogle Scholar
  23. 23.
    Eliason G, Zakrisson AB, Piehl-Aulin K, Hurtig-Wennlof A (2011) Physical activity patterns in patients in different stages of chronic obstructive pulmonary disease. COPD 8(5):369–374CrossRefPubMedGoogle Scholar
  24. 24.
    Pitta F, Breyer MK, Hernandes NA, Teixeira D, Sant’Anna TJ, Fontana AD et al (2009) Comparison of daily physical activity between COPD patients from Central Europe and South America. Respir Med 103(3):421–426CrossRefPubMedGoogle Scholar
  25. 25.
    Márin Royo M, Pellicer Ciscar C, Gonzalez Villaescusa C, Bueso Fabra MJ, Aguar Benito C, Andreu Rodriguez AL et al (2011) Physical activity and its relationship with the state of health of stable COPD patients. Arch Bronconeumol 47(7):335–342CrossRefPubMedGoogle Scholar
  26. 26.
    Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Anto JM (2007) Regular physical activity modifies smoking-related lung function decline and reduces risk of chronic obstructive pulmonary disease: a population-based cohort study. Am J Respir Crit Care Med 175(5):458–463CrossRefPubMedGoogle Scholar
  27. 27.
    Garcia-Rio F, Rojo B, Casitas R, Lores V, Madero R, Romero D et al (2012) Prognostic value of the objective measurement of daily physical activity in patients with COPD. Chest 142(2):338–346CrossRefPubMedGoogle Scholar
  28. 28.
    Garcia-Aymerich J, Lange P, Benet M, Schnohr P, Anto JM (2006) Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: a population based cohort study. Thorax 61(9):772–778PubMedCentralCrossRefPubMedGoogle Scholar
  29. 29.
    Pleguezuelos E, Pérez ME, Guirao L, Samitier B, Ortega P, Vila X et al (2013) Improving physical activity in patients with COPD with urban walking circuits. Respir Med 107(12):1948–1956CrossRefPubMedGoogle Scholar
  30. 30.
    Ng TP, Niti M, Tan WC, Cao Z, Ong KC, Eng P (2007) Depressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of life. Arch Intern Med 167(1):60–67CrossRefPubMedGoogle Scholar
  31. 31.
    Al-shair K, Dockry R, Mallia-Milanes B, Kolsum U, Singh D, Vestbo J (2009) Depression and its relationship with poor exercise capacity, BODE index and muscle wasting in COPD. Respir Med 103(10):1572–1579CrossRefPubMedGoogle Scholar
  32. 32.
    Jordan N, Lee TA, Valenstein M, Pirraglia PA, Weiss KB (2009) Effect of depression care on outcomes in COPD patients with depression. Chest 135(3):626–632CrossRefPubMedGoogle Scholar
  33. 33.
    Jehn M, Schmidt-Trucksäss A, Meyer A, Schindler C, Tamm M, Stolz D (2011) Association of daily physical activity volume and intensity with COPD severity. Respir Med 105(12):1846–1852CrossRefPubMedGoogle Scholar
  34. 34.
    Watz H, Waschki B, Meyer T, Magnussen H (2009) Physical activity in patients with COPD. Eur Respir J 33(2):262–272CrossRefPubMedGoogle Scholar
  35. 35.
    Chao PW, Ramsdell J, Renvall M, Vora C (2011) Does a history of exercise in COPD patients affect functional status? A study using a lifetime physical activity questionnaire investigates a correlation between exercise and functional status as evidenced by six-minute walk distance. COPD 8(6):429–436CrossRefPubMedGoogle Scholar
  36. 36.
    Garcia-Rio F, Lores V, Mediano O, Rojo B, Hernanz A, Lopez-Collazo E et al (2009) Daily physical activity in patients with chronic obstructive pulmonary disease is mainly associated with dynamic hyperinflation. Am J Respir Crit Care Med 180(6):506–512CrossRefPubMedGoogle Scholar
  37. 37.
    Troosters T, Gosselink R, Janssens W, Decramer M (2010) Exercise training and pulmonary rehabilitation: new insights and remaining challenges. Eur Respir Rev 19(115):24–29CrossRefPubMedGoogle Scholar
  38. 38.
    Cooper CB (2009) Desensitization to dyspnea in COPD with specificity for exercise training mode. Int J Chron Obstr Pulm Dis 4:33–43Google Scholar
  39. 39.
    Garcia-Aymerich J, Serra I, Gomez FP, Farrero E, Balcells E, Rodriguez DA et al (2009) Physical activity and clinical and functional status in COPD. Chest 136(1):62–70CrossRefPubMedGoogle Scholar
  40. 40.
    Pitta F, Troosters T, Probst VS, Spruit MA, Decramer M, Gosselink R (2006) Quantifying physical activity in daily life with questionnaires and motion sensors in COPD. Eur Respir J 27(5):1040–1055CrossRefPubMedGoogle Scholar
  41. 41.
    Miravitlles M, Izquierdo I, Herrejon A, Torres JV, Baro E, Borja J (2011) COPD severity score as a predictor of failure in exacerbations of COPD. The ESFERA study. Respir Med 105(5):740–747CrossRefPubMedGoogle Scholar
  42. 42.
    Miravitlles M, Soler-Catalunya JJ, Calle M, Molina J, Almagro P, Quintano JA et al (2012) Spanish COPD Guidelines (GesEPOC). Pharmacological treatment of stable COPD. Arch Bronconeumol 48(7):247–257CrossRefPubMedGoogle Scholar
  43. 43.
    Pitta F, Troosters T, Spruit MA, Decramer M, Gosselink R (2005) Activity monitoring for assessment of physical activities in daily life in patients with chronic obstructive pulmonary disease. Arch Phys Med Rehabil 86(10):1979–1985CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Marc Miravitlles
    • 1
    Email author
  • Jordi Cantoni
    • 2
  • Karlos Naberan
    • 3
  1. 1.Department of Pneumology, Ciber de Enfermedades Respiratorias (Ciberes)Hospital Universitari Vall d’HebronBarcelonaSpain
  2. 2.BiocleverBarcelonaSpain
  3. 3.Primary Health Care Center, Fuentes del EbroZaragozaSpain

Personalised recommendations